Acute Myeloid Leukemia With BCR-ABL1
Oncology·MeSH: Blast Crisis
Prevalence
6.0 / 100K
Incidence
4.3 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Acute Myeloid Leukemia With BCR-ABL1?
There are 1 clinical trial targeting Acute Myeloid Leukemia With BCR-ABL1 tracked by BioSniper.
What is the prevalence of Acute Myeloid Leukemia With BCR-ABL1?
The estimated prevalence of Acute Myeloid Leukemia With BCR-ABL1 is approximately 6.0 per 100,000 population.
Deep-dive into Acute Myeloid Leukemia With BCR-ABL1
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis